V-Pro maX 2 Low Temperature Sterilization System
STERIS · Decision date Oct 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-29 for the V-Pro maX 2 Low Temperature Sterilization System, submitted by STERIS of Mentor, Ohio, under 510(k) number K263530. The application was received 09/29/2026. The device falls under regulation 880.6860 with classification name Sterilizer, Chemical, product code MLR, and the regulation medical specialty and 510(k) review panel are both General Hospital.
SESE in the 510(k) pathway denotes clearance to market as substantially equivalent to a predicate device; it is not premarket approval of the system. The public record identifies no predicate device, no summary statement content, and no detail on what, if anything, changed relative to a prior version of this system. The page lists the summary type as Special, states the review was not by a third party, and records no combination product and no authorized predetermined change control plan.
Because the underlying summary and any comparison to a predicate are not included in the available text, the specific technological characteristics reviewed and the basis for the equivalence finding remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263530
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- STERIS
- Product code
- MLR
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sterilizer, Chemical.
FDA decision timeline
K263530 received
Application receipt date recorded by FDA.
K263530 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Steris
- Headquarters
- Not reported
- Brand website
- steris.com
- FDA applicant address
- Mentor, OH
Sources and methodology
- Original FDA record: K263530
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records